Antoine Makdissi is an Endocrinology/Metabolic physician affiliated with University at Buffalo. OpenAlex indexes 70 publications with 1,738 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3 Gates Cir
Buffalo, NY 142091120
Telephone
716-887-4069Registry record last updated 23 Nov 2011.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- Tandem Diabetes Care, Inc.Program year20231 payment
- Horizon Therapeutics plcProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62.5%GLP-1 receptor agonist20.6%Ozempic47%Trulicity24%Mounjaro21%Rybelsus8%Part D≥120 patientsInsulin Analog16.4%Lantus Solostar30%Humalog Kwikpen U-10018%Tresiba Flextouch U-1009%Novolog Flexpen7%Basaglar Kwikpen U-1007%Insulin Lispro Kwikpen U-1006%Tresiba Flextouch U-2005%Toujeo Max Solostar4%Humalog4%Toujeo Solostar3%Fiasp Flextouch3%Novolog2%Admelog Solostar1%Insulin Lispro1%Part D<11 patients+ 8 more classes in this area
Cardiovascular
20.4%Statin8.8%Atorvastatin Calcium64%Rosuvastatin Calcium28%Simvastatin8%Part D<11 patientsCholesterol absorption inhibitor2.8%Ezetimibe100%Part D≥47 patients+ 7 more classes in this area
Hormonal (systemic)
14.2%l-Thyroxine13.2%Levothyroxine Sodium83%Synthroid16%Levoxyl2%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.7%Methimazole100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth
The Journal of Clinical Endocrinology & Metabolism
2019 - Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes
The Journal of Clinical Endocrinology & Metabolism
2019 - Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone
Journal of the Endocrine Society
2019 - Acute effects of insulin on skeletal muscle growth and differentiation genes in men with type 2 diabetes
European Journal of Endocrinology
2019 - Abstract #581 Different Facets of Autoimmunity-Stiff Person Syndrome in Graves’ Disease
Endocrine Practice
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Anne Curtis, MD
University at Buffalo
Paresh Dandona, MD
University at Buffalo
Gil Wolfe, MD
University at Buffalo
Uriel Halbreich, MD
University at Buffalo
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”